SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023193
Filing Date
2024-06-07
Accepted
2024-06-07 17:23:08
Documents
17
Period of Report
2024-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42891
2 ex1-1.htm EX-1.1 267177
3 ex5-1.htm EX-5.1 27456
4 ex5-1_001.jpg GRAPHIC 2825
  Complete submission text file 0001493152-24-023193.txt   580000

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT thar-20240607.xsd EX-101.SCH 3021
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT thar-20240607_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT thar-20240607_pre.xml EX-101.PRE 22363
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3791
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 241030740
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)